Sciensus (formerly Healthcare at Home) is a global life sciences business established in 1992 by founder and former chairman Charles Walsh based in London.
In March 2014 Healthcare at Home said that it was no longer accepting new ‘high risk’ patients such as those suffering from haemophilia or respiratory diseases like cystic fibrosis because it could not guarantee getting their drugs to them on time or in full.
Dave Roberts, chief executive of the National Clinical Homecare Association, says there are questions about whether the rapid growth and low profit margins in the sector have contributed to the situation.
[10] The chief executive Mike Gordon stepped down in June 2014 after the revelation that seven per cent of the firm's 150,000 patients had not received their medication on time or in full during the last six months.
[11] In May 2021 it was reported that the firm had missed almost 10,000 medicine deliveries when it introduced a new IT system in October 2020 and it was put in special measures by the Care Quality Commission.